AffaMed Therapeutics
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A specialty pharma company bringing innovative ophthalmology and CNS therapies, especially for rare diseases, to Greater China.
OphthalmologyNeuroscienceRare Disease
Technology Platform
A development and commercialization platform specialized in in-licensing and accelerating late-stage ophthalmology and CNS therapies for the Greater China and Asian markets.
Opportunities
Addressing the large and growing demand for specialized, high-value medicines in China's rapidly evolving healthcare system.
Risk Factors
Reliance on third-party for pipeline assets and exposure to pricing/reimbursement pressures in its core markets.
Competitive Landscape
Competes as a regional development and commercialization partner against other China-focused biopharma firms and local subsidiaries of global companies.